BioForce Nanosciences Holdings (BFNH) Stock Statistics & Valuation Metrics

BioForce Nanosciences Holdings has a market cap or net worth of $63.74M. The enterprise value is $59.71M.

BioForce Nanosciences Holdings has 33,549,004 shares outstanding. The number of shares has decreased by -2.65% in one year.

BioForce Nanosciences Holdings’s return on equity (ROE) is 2.09 and return on invested capital (ROIC) is 79.21%.

The current PE Ratio of BioForce Nanosciences Holdings is ―. BioForce Nanosciences Holdings’s PEG ratio is -0.11.

In the last 12 months, BioForce Nanosciences Holdings had revenue of 0.00 and earned -1.29M in profits. Earnings per share was -0.04.

In the last 12 months, operating cash flow was -42.85K and capital expenditures 0.00, giving a free cash flow of -42.85K billion.

BioForce Nanosciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

BioForce Nanosciences Holdings upcoming earnings date is May 11, 2018, After Close (Confirmed).

BioForce Nanosciences Holdings as a current ratio of <0.01, with Debt / Equity ratio of -13.84%

In the past 12 months, BioForce Nanosciences Holdings has paid 0.00 in taxes.

BioForce Nanosciences Holdings EV to EBITDA ratio is -39.31, with an EV/FCF ratio of -295.62.

BioForce Nanosciences Holdings has $6.35K in cash and marketable securities with $99.76K in debt, giving a net cash position of -$93.42K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for BioForce Nanosciences Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―